Features of iNOS activity in the skin lesions of patients with psoriasis and concomitant hypertension
DOI:
https://doi.org/10.14739/2310-1237.2016.2.80990Keywords:
iNOS, immunohistochemistry, psoriasis, hypertensionAbstract
Objective: To identify the features of the activity of nitric oxide synthase by immunohistochemical study of skin samples in patients with psoriasis and concomitant hypertension.
Materials and methods. Specimens for immunohistochemical studies were taken from the surgical specimens of 40 psoriasis patients, including 20 with psoriasis and essenthial hypertension, 20 only with psoriasis, the control group consisted of 20 healthy individuals. For the diagnosis of the basic processes in the skin histopathological paraffin tissue sections were stained with hematoxylin and eosin. Immunohistochemical determination of iNOS marker expression was performed using rabbit polyclonal antibodies to iNOS.
Results. Healthy skin cells showed almost no expressive staining during immunohistochemical determination of iNOS in the cells of the epidermis and dermis. When conducting similar studies of skin fragments of psoriasis patients a large number of positively stained cells in the epidermis, namely the basal, spinous and granular layers, were observed. Expression of iNOS in the investigated preparations looked as intracytoplasmic light and dark brown granules, which provided a homogeneous staining of cells of varying intensity. Cells of dermis in the papillary and reticular layer showed intense dark brown color of the majority of immune cells and fibroblasts. It was revealed that in the areas of skin lesions in patients with psoriasis and hypertension more cells and more intense immunohistochemical staining of the epidermis and dermis in the form of numerous moderate and dark brown intracytoplasmic inclusions were observed.
Conclusions. When comparing the level of іNOS expression by U-Mann-Whitney test, a significant difference between the expression of iNOS in the epidermis in isolated psoriatic lesions and psoriasis in combination with hypertension (p <0.05) with significantly higher levels of expression in patients with comorbid disorders was established. In the dermis of the skin in patients with isolated psoriasis significantly lower iNOS expression was found in comparison with the psoriasis and hypertension patients skin (p <0.05).
References
Belovol, A. N. (2010) Disfunkciya sosudistogo `endoteliya u bol'nykh psoriazom [Disfunction of vascular endotelium at patients with psoriasis]. Ukrainskyi zhurnal dermatolohii, venerolohii, kosmetolohii, 1(36), 17–21. [in Ukrainian].
Metelskaya, V. A., & Gumanova, N. G. (2005) Skrining-metod opredeleniya urovnya metabolitov oksida azota v syvorotke krovi [Screening as a method for determining the serum level of nitric oxide metabolites]. Klinicheskaya laboratornaya diagnostika, 6, 15–18. [in Russian].
Syniachenko, O. V., Zviahina, T. V., Diakov, I. M., Hryn, V. K., Nikolenko, Yu. I., (2001) Metabolity oksydu azotu v krovi tvaryn z eksperymentalnym autoimunnym zakhvoriuvanniam [The metabolites of nitric oxide in the blood of animals with experimental autoimmune disease]. Ukrainskyi revmatolohichnyi zhurnal, 3/4., 83–85. [in Ukrainian].
Smirnova, I. Yu., Ogorodova, L. M., Deyev, I. A. (2009) Rol' oksida azota v razvitii zabolevanij kozhi [The role of nitric oxide in development of skin diseases]. Voprosy sovremennoj pediatrii, 8(4), 90–94. [in Russian].
Sukolina, O. G., & Batkaev, E´. A. Rol' oksida azota v patogeneze psoriaza [The role of nitric oxide in the pathogenesis of psoriasis]. Rossijskij zhurnal kozhnykh i venericheskikh boleznej, 1, 21–24. [in Russian].
Bruch-Gerharz, D., Schnorr, C., Suschek, S., et al. (2001) Arginase 1 overexpression in psoriasis. Limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Amerian J. Pathol, 173, 2375–2381.
Bruch-Gerharz, D., Schnorr, O., Suschek, C., Beck, K. F., Pfeilschifter, J., Ruzicka, T., & Kolb-Bachofen, V. (2003) Limitation of Inducible Nitric Oxide Synthase Activity as a Molecular Mechanism for Keratinocyte Hyperproliferation. Am J Pathol, 162(1), 203–211. doi: 10.1016/S0002-9440(10)63811-4.
Cals-Grierson, M.-M., & Ormerod, A. D. (2004) Nitric oxide functionin the skin. Nitricoxide, 10, 179–193. doi: 10.1016/j.niox.2004.04.005.
Gokhale, N. R., Belgaumkar, V. A., Pandit, D. P., Deshpande, S., & Damle, D. K. (2005) A study of serum nitric oxide levels in psoriasis. Indian J. DermatolVenerol. Leprol., 71(3), 198–203. doi: 10.4103/0378-6323.16232.
Rashed Hayam, E., & Abd El-Bary, Eman H. (2012) Immunohistochemical evaluation of VEGF, survivin, bcl-2 protein and iNOS in the pathogenesis of psoriasis. Egyptian Journal of Pathology, 32, 91–98. doi: 10.1097/01.XEJ.0000417556.36570.93.
Ricciardolo, F. L., Sterk, P. J., Gaston, B., & Folkerts, G. (2004) Nitric oxide in health and disease of the respiratory system. Physiol. Rev, 84, 731–765. doi: 10.1152/physrev.00034.2003.
Salem, A., Nasar, A., Kandil, A., Farag, R., & El-Kasheshy, K. (2014) Role of vascular endothelial growth factor, survivin, and inducible nitric oxide synthase expression in psoriasis: an immunohistochemical study. Egypt JDermatol Venerol, 34, 21–26. doi: 10.4103/1110-6530.137262.
Sirsjo, A., Karlsson, M., Gidlof, A., Rollman, O., & Törmä, H. (1996) Increase dexpression of inducible nitric oxide synthase in psoriatic skin and cytokine stimulated cultured keratinocytes. J. Dermatol, 134, 643–648. doi: 10.1111/j.1365-2133.1996.tb06963.x.
Dabbs D. J. (Ed.) (2010) Diagnostic Immunohistochemistry. Philadelphia: Saunders/Elsevier.
Rasband, W.S. (1997–2016) National Institutes of Health. Bethesda, Maryland. – 1997–2016. Retrived from http://imagej.nih.gov/ij/.
Tumanskyi, V. O., Yevsieiev, A. V., Kovalenko, I. S., Zubko, M. D. (2015) Patent Ukrainy na korysnu model №99314 Ukraina, MPK (2015) G01N 21/00, G06K 9/00. Sposib foto tsyfrovoi morfometrii imunohistokhimichnykh preparativ [Ukraine Utility model patent number 99314, MPK (2015) G01N 21/00, G06K 9/00. The Method of digital photo morphometry of immunohistochemical preparations]. Biuleten, 10. [in Ukrainian].
Kubanova, A. A., Nikolas, J. F., Puig L., Prince J., Katunina, O. R., & Znamenskaya, L. F. (2010) Immunnye mekhanizmy psoriaza. Novye strategii biologicheskoj terapii [Immune mechanisms of psoriasis. New strategies of biotherapy]. Vestnik dermatoljgii i veneroljgii, 1, 35–47. [in Russian].
Henseler, T., & Christophers, A. (1995) Disease concomitance in psoriasis. J. Am. Acad. Dermatol, 32, 982–986. doi: 10.1016/0190-9622(95)91336-X.
Boehncke, W. H., Boehncke, S., Tobin, A. M., & Kirby, B. (2011) The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp. Dermatol, 20, 303–307. doi: 10.1111/j.1600-0625.2011.01261.x.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
